At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,488 enrolled
Drug / intervention
non-invasive prenatal testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
National Prevalence and Impact of Noninvasive Prenatal Testing
In Brief
An observational study evaluating non-invasive prenatal testing for Aneuploidy. Completed, enrolled 4,488 participants across 7 sites.
Detailed Summary
Information on pregnant women undergoing non-invasive prenatal testing (NIPT) at one of the Obstetrix Medical Groups Outpatient Centers between January 2012 and June 2014 will be retrospectively gathered and an analysis of the impact and prevalence of NIPT. This will be compared to a control group of pregnant women in those same practices undergoing prenatal testing during the months of January 2010-July 2010.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAneuploidy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedNov 2014
Primary CompletionJun 2016
Study CompletionDec 2016
TodayJul 2026
First PostedNov 6, 2014
Enrollment StartJan 1, 2014
Primary CompletionJun 28, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 11.7 years ago
Interventions
non-invasive prenatal testingother
Noninvasive Prenatal Testing (NIPT) of fetal cell free DNA in maternal circulation